IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1316.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Aspirin reverses obesity cancer risk
Research has shown that a regular dose of aspirin reduces the long-term risk of cancer in those who are overweight in an international study of people with a family history of the disease.
Medical Research Council, Cancer Research UK, European Union, Bayer Pharma

Contact: Helen Rae
helen.rae@ncl.ac.uk
44-019-120-87374
University of Leeds

Public Release: 17-Aug-2015
Journal of Clinical Oncology
First-of-its-kind study finds music therapy lowers anxiety during surgical breast biopsies
A first-of-its-kind study published in the Journal of Clinical Oncology finds that music therapy lessened anxiety for women undergoing surgical breast biopsies for cancer diagnosis and treatment. The two-year study out of University Hospitals Seidman Cancer Center involved 207 patients.
Kulas Foundation

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-2555
University Hospitals Case Medical Center

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Genetic test could improve blood cancer treatment
Testing for genetic risk factors could improve treatment for myeloma -- a cancer of the blood and bone marrow -- by helping doctors identify patients at risk of developing more aggressive disease. New research, published in the Journal of Clinical Oncology today (Monday), found as few as nine genetic features would need to be tested to identify high-risk patients who might benefit from intensive treatment.
Myeloma UK, Cancer Research UK, NIHR Biomedical Research Centre at The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research

Contact: Claire Hastings
chastings@icr.ac.uk
020-715-35380
Institute of Cancer Research

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Drinking coffee daily may improve survival in colon cancer patients
Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study from Dana-Farber Cancer Institute that reported this striking association for the first time.
National Institutes of Health, Alliance for Clinical Trials in OncologyPharmacia, Upjohn Companythe National Cancer Institute

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Drinking coffee daily may improve survival in colon cancer patients
Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study from Dana-Farber Cancer Institute that reported this striking association for the first time.
NIH/National Cancer Institute, Pharmacia & Upjohn Company, Pfizer Oncology, National Institutes of Health

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Public Release: 17-Aug-2015
Nature Cell Biology
MD Anderson study reveals new insight into tumor progression
Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.

Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center

Public Release: 14-Aug-2015
Science Advances
Revealed -- Helicobacter pylori's secret weapon
Is the game up for Helicobactor pylori? Researchers in the School of Pharmacy, at The University of Nottingham and AstraZeneca R&D have identified the molecular mechanism that the bacterium's best-known adhesion protein uses to attach to stomach sugars and evade the body's attempts to 'flush' it away.
EPSRC and AstraZeneca Centre for Doctoral Training in Targeted Therapeutics

Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-011-595-15751
University of Nottingham

Public Release: 14-Aug-2015
Nature Communications
The protein that keeps cells static is found to play a key role in cell movement
The protein E-Cadherin is a kind of adhesive that keeps cells tightly bound together, thus favouring the organisation of tissues and organs. Scientists at the Institute for Research in Biomedicine now reveal a new function for E-Cad, one that contrasts with its accepted role in impeding cell movement. The researchers have published an article in Nature Communications in which they report that this protein is crucial for the coordinated movement of diverse cell types.

Contact: Sònia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)

Public Release: 14-Aug-2015
EBioMedicine
Novel diagnostic tool for ethnically diverse non-small-cell lung cancer patients
Early-stage Non-small-cell Lung Cancer is asymptomatic and difficult to detect since no blood test for NSCLC is currently available. In a new study, Chen-Yu Zhang and Chunni Zhang's group at Nanjing Advanced Institute for Life Sciences, Nanjing University identified a panel of five serum microRNAs as the potential biomarker for NSCLC diagnosis. The study is published this week in the journal EBioMedicine.
National Basic Research Program of China (973 Program), Research Special Fund for Public Welfare Industry of Health of China, National Natural Science Foundation of China

Contact: Xi Chen
lisacx86@nju.edu.cn
0086-258-368-6234
Nanjing University School of Life Sciences

Public Release: 14-Aug-2015
European Journal of Epidemiology
No link found between PTSD and cancer risk
In the largest study to date that examines Post Traumatic Stress Disorder as a risk factor for cancer, researchers from Boston University School of Medicine, have shown no evidence of an association.

Contact: Gina DiGravio
ginad@bu.edu
617-638-8480
Boston University Medical Center

Public Release: 14-Aug-2015
Cell
Newly discovered cells restore liver damage in mice without cancer risk
The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the National Institutes of Health discovered a type of cell in mice essential to the process. The researchers also found similar cells in humans.
NIH/National Institute of Environmental Health Sciences

Contact: Virginia Guidry
virginia.guidry@nih.gov
919-541-1993
NIH/National Institute of Environmental Health Sciences

Public Release: 13-Aug-2015
JAMA Oncology
Screening for breast/ovarian cancer risk genes other than BRCA1/2 is clinically valuable
A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that can change clinical recommendations for patients and their family members.
MGH Friends Fighting Breast Cancer, Tracey Davis Memorial Fund, Breast Cancer Research Foundation

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital

Public Release: 13-Aug-2015
JAMA Oncology
Multigene panel testing for hereditary breast/ovarian cancer risk assessment
Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article published online by JAMA Oncology.

Contact: Katie Marquedant
kmarquedant@mgh.harvard.edu
617-726-0337
The JAMA Network Journals

Public Release: 13-Aug-2015
Cell Reports
Corrected protein structure reveals drug targets for cancer, neurodegenerative diseases
Protein Kinase C is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death. When it goes awry, a number of diseases may result. In a study, researchers at University of California, San Diego School of Medicine reveal a more accurate structure of PKC, providing new targets for fine-tuning the enzyme's activity as needed to improve human health.
National Institutes of Health, National Science Foundation

Contact: Heather Buschman
hbuschman@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 13-Aug-2015
Cell
New research helps explain why a deadly blood cancer often affects children with malaria
Children in equatorial Africa who suffer from malaria are at high risk of developing Burkitt's lymphoma, a highly aggressive blood cancer. A new study sheds light on the long-standing mystery of how the two diseases are connected.

Contact: Wynne Parry
wparry@rockefeller.edu
212-327-7789
Rockefeller University

Public Release: 13-Aug-2015
Cell
How the malaria parasite increases the risk of blood cancer
A link between malaria and Burkitt's lymphoma was first described more than 50 years ago, but how a parasitic infection could turn immune cells cancerous has remained a mystery. Now, in the Aug. 13 issue of Cell, researchers demonstrate in mice that B cell DNA becomes vulnerable to cancer-causing mutations during prolonged combat against the malaria-causing Plasmodium falciparum.
National Institutes of Health, Worldwide Cancer Research, Fondazione Ettore e Valeria Rossi

Contact: Joseph Caputo
jcaputo@cell.com
617-397-2802
Cell Press

Public Release: 13-Aug-2015
Nanomedicine: Nanotechnology, Biology, and Medicine
Advance in photodynamic therapy offers new approach to ovarian cancer
Researchers have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.
Medical Research Foundation of Oregon

Contact: Oleh Taratula
oleh.taratula@oregonstate.edu
503-346-4704
Oregon State University

Public Release: 13-Aug-2015
Journal of Investigative Dermatology
Transplant recipients more likely to develop aggressive melanoma
Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student.
NIH/National Cancer Institute

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 13-Aug-2015
JAMA Oncology
Mayo Clinic-led study validates tool for pt. reporting side effects in cancer clinical trials
A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events, was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.
NIH/National Cancer Institute

Contact: Jim McVeigh
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 13-Aug-2015
PLOS ONE
A better way to personalize bladder cancer treatments
Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer. In early proof-of-concept research, the team took bladder tumors from individual patients, identified actionable mutations and grafted the tumors into mice.
Veteran Administration, NIH/National Cancer Institute, The Laney Foundation

Contact: Carole Gan
cfgan@ucdavis.edu
916-734-9040
University of California - Davis Health System

Public Release: 13-Aug-2015
International Journal of Obesity
Heavy smokers and smokers who are obese gain more weight after quitting
For smokers, the number of cigarettes smoked per day and current body mass index are predictive of changes in weight after quitting smoking, according to researchers at Penn State College of Medicine.
Penn State Hershey Cancer Institute

Contact: Matt Solovey
msolovey@hmc.psu.edu
717-531-8606
Penn State

Public Release: 12-Aug-2015
Cancer Research
Combining chemotherapy with an immune-blocking drug could stop cancer growing back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published in Cancer Research.
Cancer Research UK, Medical Research Council, Wellcome Trust

Contact: Liz Smith
liz.smith@cancer.org.uk
020-346-98300
Cancer Research UK

Public Release: 12-Aug-2015
Cancer Discovery
Pancreas cancer spread from multiple types of wayward cells
Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs. Groups of these cancer cells are better than single cancer cells in driving tumor spread. These results may prove useful in designing better targeted therapies to stop tumor progression and provide an improved non-invasive method for detecting early disease states in this highly lethal cancer.
NIH/National Cancer Institute, Penn Center for Molecular Studies in Digestive and Liver Diseases, Paul Calabresi Career Development Award, Abramson Family Cancer Research Institute

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 12-Aug-2015
Journal of American Geriatrics Society
UTHealth research: Older breast cancer patients less likely to benefit from chemo
Chemotherapy prolongs life for older adults with most types of cancer, but for women over the age of 80 with breast cancer, the chances of survival due to chemotherapy are significantly lower, according to a study led by researchers from The University of Texas Health Science Center at Houston (UTHealth).
Agency for Healthcare Research and Quality, Cancer Prevention Research Institute of Texas

Contact: Hannah Rhodes
Hannah.C.Rasorrhodes@uth.tmc.edu
713-500-3053
University of Texas Health Science Center at Houston

Public Release: 12-Aug-2015
Journal of Biological Chemistry
Can stem cells cause and cure cancer?
Simply put, cancer is caused by mutations to genes within a cell that lead to abnormal cell growth. Finding out what causes that genetic mutation has been the holy grail of medical science for decades. Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology believe they may have found one of the reasons why these genes mutate and it all has to do with how stem cells talk to each other.
National Institutes of Health, Cancer Prevention and Research Institution of Texas Grant, Natural Science Foundation of Zhejiang Province of China, National Natural Science Foundation of China

Contact: Holly Shive
hshive@tamhsc.edu
979-436-0613
Texas A&M University

Showing releases 76-100 out of 1316.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

  Search News Releases

     

 

EurekAlert!